Top 17 results related to the keyword tag disorder

Research/Project Funding Opportunity

Posted 18 hours ago

Notice of Correction to RFA-HL-26-014 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 8 months ago

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 8 months ago

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Notice of Correction to Key Dates for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Notice of Extension of the Expiration Date for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Notice of NICHD Withdrawal from Participation in PAR-24-063 " Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Notice of NICHD Withdrawal from Participation in PAR-24-043 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Contract/Tender

Posted 1 year ago

Notice of Change: Extension of PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Contract/Tender

Posted 1 year ago

Notice of Change: Extension of PAR-21-233 "Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System U44"
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 2 years ago

Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 2 years ago

Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
at National Institutes of Health in États-Unis
0 0 National Institutes of Health
Fellowship

Posted 2 years ago

Recovery Community Services Program
at Department of Health and Human Services Substance Abuse and Mental Health Services Adminis in États-Unis
0 0 Department of Health and Human Services Substance Abuse and Mental Health Services Adminis
Fellowship

Posted 2 years ago

Rural Emergency Medical Services Training
at Department of Health and Human Services Substance Abuse and Mental Health Services Adminis in États-Unis
0 0 Department of Health and Human Services Substance Abuse and Mental Health Services Adminis
Research/Project Funding Opportunity

Posted 3 years ago

Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
at Department of Health and Human Services National Institutes of Health in États-Unis
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 4 years ago

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in États-Unis
0 0 Department of Health and Human Services National Institutes of Health

Discover 17 opportunities in disorder

Notice of Correction to RFA-HL-26-014 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Notice of Correction to Key Dates for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"

Notice of Extension of the Expiration Date for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"

Notice of NICHD Withdrawal from Participation in PAR-24-063 " Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Notice of NICHD Withdrawal from Participation in PAR-24-043 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Notice of Change: Extension of PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)

Notice of Change: Extension of PAR-21-233 "Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System U44"

Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)

Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Recovery Community Services Program

Rural Emergency Medical Services Training

Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)